- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05391113
REward SYSTem in Autism Spectrum Disorder and Addictive Disorder (RESYSTAA)
Stimuli Sociaux et Non-sociaux du système de récompense : Une étude en IRM Chez Des Sujets Avec Trouble du Spectre de l'Autisme et Des Sujets Avec un Trouble Addictif à l'Alimentation. - RESYSTAA
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Wiebe de JONG, MSc
- Phone Number: +33247474680
- Email: w.dejong@chu-tours.fr
Study Contact Backup
- Name: Frédéric BRIEND, PhD
- Phone Number: +33247478519
- Email: frederic.briend@univ-tours.fr
Study Locations
-
-
-
Tours, France, 37044
- Recruiting
- Center-Val de Loire Region Autism Resource Center
-
Contact:
- Emmanuelle HOUY-DURAND, MD-PhD
- Phone Number: +3318370545
- Email: E.HOUY-DURAND@chu-tours.fr
-
Principal Investigator:
- Frédéric BRIEND, PhD
-
Sub-Investigator:
- Marianne LATINUS, PhD
-
Sub-Investigator:
- Laurent BARANTIN, PhD
-
Sub-Investigator:
- Emmanuelle HOUY-DURAND, MD-PhD
-
Tours, France, 37044
- Recruiting
- University Addictology Service, Liaison Team and Addictology Care
-
Contact:
- Paul BRUNAULT, MD-PhD
- Phone Number: 72882 +33247474747
- Email: paul.brunault@univ-tours.fr
-
Sub-Investigator:
- Paul BRUNAULT, MD-PhD
-
Tours, France, 37044
- Recruiting
- University Hospital, Medical Imaging Service
-
Contact:
- Jean-Philippe COTTIER, MD-PhD
- Phone Number: +33234379615
- Email: cottier@med.univ-tours.fr
-
Sub-Investigator:
- Jean-Philippe COTTIER, MD-PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Arm A ˗ Concerning ASD patients: Adult carrying the diagnosis of ASD (DSM-5, ADOS, ADI-R criteria)
Arm B ˗ Concerning FAD patients: Adult diagnosed with FA presenting with food addiction (DSM-5, YFAS 2.0, BES >= 18 criteria).
Arm C ˗ Concerning healthy volunteers : Adult with no neurological and psychiatric history , absence of progressive somatic pathologies or with vital risk.
For all participants:
- Age greater than or equal to 18 years old
- Without intellectual delay (IQ > 70).
- Able to understand and apply the instruction when an active task is proposed, according to the estimate of the investigator.
- Free, express, informed and written consent of the participant.
- Participant affiliated to a social security scheme
Exclusion Criteria:
- Neuromotor disorders.
- Visual disturbances not corrected or incompatible with MRI.
- Known epilepsy.
- Current substance use disorder with emotional distress/significant impact on functional outcome
- Rare genetic syndrome.
- Contraindications to MRI (other than body circumference)
- For women of childbearing age: negative urine or blood pregnancy test
- Person subject to a measure of judicial protection (safeguard of justice, curatorship, guardianship or family authorization)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Autism Spectrum Disorder
Characterized by two main diagnostic criteria: a socio-emotional deficit via a defect in communication and social reciprocity, and a behavioral deficit which manifests itself in repetitive behavioral patterns (stereotypes), restricted interests and/or activities.
|
an fMRI measurement of the BOLD physiological signal for sensory responses
Other Names:
These tests, through videos with a social or non-social content (human presence or absence on the stereoscopic projection), will allow us to study two types of sensorialities (visual and interoceptive).
Thus, it will be possible to obtain inter- and exteroceptive profiles of the participants, a direct reflection of the processing of the internal bodily sensations of the body.
Other Names:
|
Active Comparator: Food Addictive Disorders
Characterized by regroup substance use disorders and behavioral addictions, are characterized in particular by the repeated occurrence of compulsive behavior and impaired social functioning
|
an fMRI measurement of the BOLD physiological signal for sensory responses
Other Names:
These tests, through videos with a social or non-social content (human presence or absence on the stereoscopic projection), will allow us to study two types of sensorialities (visual and interoceptive).
Thus, it will be possible to obtain inter- and exteroceptive profiles of the participants, a direct reflection of the processing of the internal bodily sensations of the body.
Other Names:
|
Placebo Comparator: Healthy volonteers
Adult without neurological and psychiatric history, absence of progressive somatic pathologies or with vital risk.
|
an fMRI measurement of the BOLD physiological signal for sensory responses
Other Names:
These tests, through videos with a social or non-social content (human presence or absence on the stereoscopic projection), will allow us to study two types of sensorialities (visual and interoceptive).
Thus, it will be possible to obtain inter- and exteroceptive profiles of the participants, a direct reflection of the processing of the internal bodily sensations of the body.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Oxygene Level Dependent (BOLD) MRI signal
Time Frame: At inclusion
|
Measurement in fMRI of the BOLD signal for each condition (interest, addiction, social) will be carried out in order to highlight the possible alterations of the reward system, in particular at the level of the striatum in terms of cerebral activation for each of the groups of subjects.
(FAD, ASD and HV).
|
At inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Tolerance to an MRI examination for FAD with overweight or obesity
Time Frame: At inclusion
|
For the tolerance to an MRI examination for FAD with overweight or obesity: feedback on their experience in MRI.
|
At inclusion
|
Regulation of sensory, an fMRI measurement of the BOLD physiological signal for sensory responses (sensory block) in terms of brain activation in patients
Time Frame: At inclusion
|
Regulation of sensory, an fMRI measurement of the BOLD physiological signal for sensory responses (sensory block) in terms of brain activation in patients with FAD compared to ASD subjects and healthy volunteers.
|
At inclusion
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Frédéric BRIEND, PhD, University Hospital,Tours -INSERM U1253 iBrain
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DR220016-RESYSTAA
- 2022-A01098-35 (Registry Identifier: ID RCB-ANSM)
- 22-87 (Registry Identifier: CPP SUD-MED IV)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on MRI
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingMultiple SclerosisFrance
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom
-
Seoul National University Bundang HospitalBayerCompletedTraumaKorea, Republic of
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOsteosarcoma | Ewing Sarcoma | Paget's DiseaseUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
University of EdinburghActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisUnknownBrain Injury, Coma | Cardiac Arrest (CA) | Traumatic Brain Injury (TBI) | Aneurysmal Subarachnoid Hemorrhages (aSAH)France
-
Sheba Medical CenterUnknown
-
University of ZurichBalgrist University HospitalNot yet recruiting
-
Bragee ClinicsNot yet recruitingChronic Fatigue Syndrome